{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T11:14:42Z","timestamp":1789384482896,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1746-1","type":"journal-article","created":{"date-parts":[[2016,10,10]],"date-time":"2016-10-10T07:15:39Z","timestamp":1476083739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia"],"prefix":"10.1186","volume":"16","author":[{"given":"Aschalew","family":"Tamiru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethlehem","family":"Tigabu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisay","family":"Yifru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ermias","family":"Diro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asrat","family":"Hailu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,10]]},"reference":[{"issue":"5","key":"1746_CR1","doi-asserted-by":"crossref","first-page":"e35671","DOI":"10.1371\/journal.pone.0035671","volume":"7","author":"J Alvar","year":"2012","unstructured":"Alvar J, Velez ID, Bern C, Herrero M, Desjeux P, Cano J, et al. Leishmaniasis worldwide and global estimates of its incidence. PloS One. 2012;7(5):e35671.","journal-title":"PloS One"},{"key":"1746_CR2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S1473-3099(02)00347-X","volume":"2","author":"PJ Guerin","year":"2002","unstructured":"Guerin PJ, Piero O, Shyam S. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis. 2002;2:494\u2013501.","journal-title":"Lancet Infect Dis"},{"key":"1746_CR3","volume-title":"Armauer Hansen Research Institute\/ALERT- Consultative Meeting on the Control of Leishmaniasis in the African Region","author":"A Aseffa","year":"2010","unstructured":"Aseffa A. Armauer Hansen Research Institute\/ALERT- Consultative Meeting on the Control of Leishmaniasis in the African Region. Addis Ababa: WHO\/AFRO; 2010."},{"key":"1746_CR4","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1756-3305-5-240","volume":"5","author":"D Kebede","year":"2012","unstructured":"Kebede D, Kadu M, Teshome G, et al. The burden of neglected tropical diseases in Ethiopia, and opportunities for integrated control and elimination. Parasites Vectors. 2012;5:240.","journal-title":"Parasites Vectors"},{"key":"1746_CR5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(83)92588-6","volume":"1","author":"GM Anabwani","year":"1983","unstructured":"Anabwani GM, Ngira JA, Dimiti G, Bryceson AD. Comparison of two dosage schedules of sodium stibogluconate in the treatment of visceral leishmaniasis in Kenya. Lancet. 1983;1:210\u20133.","journal-title":"Lancet."},{"key":"1746_CR6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","volume":"46","author":"BL Herwaldt","year":"1992","unstructured":"Herwaldt BL, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg. 1992;46:296\u2013306.","journal-title":"Am J Trop Med Hyg."},{"key":"1746_CR7","first-page":"9","volume":"1","author":"Lianet and Monzote","year":"2009","unstructured":"Lianet and Monzote. Current treatment of leishmaniasis; a review. Open J Antimicrob Agents. 2009;1:9\u201319.","journal-title":"Open J Antimicrob Agents"},{"issue":"2","key":"1746_CR8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.7326\/0003-4819-127-2-199707150-00007","volume":"127","author":"S Sundar","year":"1997","unstructured":"Sundar S, Agrawal NK, Sinha PR, Horwith GS, Murray HW. Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony. Ann Intern Med. 1997;127(2):133\u20137.","journal-title":"Ann Intern Med"},{"issue":"2","key":"1746_CR9","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1472-8206.2003.00168.x","volume":"17","author":"P Minodier","year":"2003","unstructured":"Minodier P, Retornaz K, Horelt A, Garnier JM. Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients. Fundam Clin Pharmacol. 2003;17(2):183\u20138.","journal-title":"Fundam Clin Pharmacol"},{"issue":"2","key":"1746_CR10","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4269\/ajtmh.2010.10-0156","volume":"83","author":"PK Sinha","year":"2010","unstructured":"Sinha PK, Roddy P, Palma PP, Kociejowski A, Lima MA, Rabi Das VN, et al. Effectiveness and safety of liposomal amphotericin B for visceral leishmaniasis under routine program conditions in Bihar, India. Am J Trop Med Hyg. 2010;83(2):357\u201364.","journal-title":"Am J Trop Med Hyg."},{"issue":"12","key":"1746_CR11","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1093\/cid\/cir674","volume":"53","author":"K Ritmeijer","year":"2011","unstructured":"Ritmeijer K, ter Horst R, Chane S, Aderie EM, Piening T, Collin SM, et al. Limited effectiveness of high-dose liposomal amphotericin B (liposomal amphotericin B) for treatment of visceral leishmaniasis in an Ethiopian population with high HIV prevalence. Clin Infect Dis. 2011;53(12):e152\u20138.","journal-title":"Clin Infect Dis"},{"key":"1746_CR12","volume-title":"Report of a WHO informal consultation on liposomal amphotericin B in the treatment of visceral leishmaniasis, Rome, Italy","author":"World Health Organization","year":"2007","unstructured":"World Health Organization. Report of a WHO informal consultation on liposomal amphotericin B in the treatment of visceral leishmaniasis, Rome, Italy. Geneva: WHO; 2007. Report No.: WHO\/ CDS\/NTD\/IDM\/2007.4."},{"key":"1746_CR13","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1111\/j.1469-0691.2011.03630.x","volume":"17","author":"SL Croft","year":"2011","unstructured":"Croft SL, Olliaro P. Leishmaniasis chemotherapy: challenges and opportunities. Clin Microbiol Infect. 2011;17:1478\u201383.","journal-title":"Clin Microbiol Infect."},{"key":"1746_CR14","unstructured":"Control of the leishmaniases: report of a meeting of the WHO Expert Committee on Control of Leishmaniases. Geneva: WHO Technical Report Series 949; 2010. p.186."},{"issue":"1","key":"1746_CR15","first-page":"25","volume":"76","author":"JD Berman","year":"1998","unstructured":"Berman JD, Badaro R, Thakur CP, Wasunna KM, Behbehani K, Davidson R, et al. Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries. Bull World Health Organ. 1998;76(1):25\u201332.","journal-title":"Bull World Health Organ"},{"issue":"10","key":"1746_CR16","doi-asserted-by":"crossref","first-page":"e709","DOI":"10.1371\/journal.pntd.0000709","volume":"4","author":"A Hailu","year":"2010","unstructured":"Hailu A, Musa A, Wasunna M, Balasegaram M, Yifru S, Mengistu G, et al. Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial. PLoS Negl Trop Dis. 2010;4(10):e709.","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"1746_CR17","doi-asserted-by":"crossref","first-page":"513","DOI":"10.4269\/ajtmh.14-0259","volume":"92","author":"S Sundar","year":"2015","unstructured":"Sundar S, Singh A, Rai M, Chakravarty J. Single-dose indigenous liposomal amphotericin B in the treatment of Indian visceral leishmaniasis: a phase 2 study. Am J Trop Med Hyg. 2015;92(3):513\u20137.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"1746_CR18","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","volume":"362","author":"S Sundar","year":"2010","unstructured":"Sundar S, Chakravarty J, Agarwal D, Rai M, Murray HW. Single-dose liposomal amphotericin B for visceral leishmaniasis in India. N Engl J Med. 2010;362(6):504\u201312.","journal-title":"N. Engl. J. Med."},{"key":"1746_CR19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0924-8579(00)00312-5","volume":"17","author":"CP Thakur","year":"2001","unstructured":"Thakur CP. A single high dose treatment of kala-azar with liposomal amphotericin B (amphotericin B lipid complex): a pilot study. Int J Antimicrob Agents. 2001;17:67\u201370.","journal-title":"Int J Antimicrob Agents."},{"issue":"1","key":"1746_CR20","doi-asserted-by":"crossref","first-page":"e2613","DOI":"10.1371\/journal.pntd.0002613","volume":"8","author":"EA Khalil","year":"2014","unstructured":"Khalil EA, Weldegebreal T, Younis BM, Omollo R, Musa AM, Hailu W, et al. Safety and efficacy of single dose versus multiple doses of liposomal amphotericin B for treatment of visceral leishmaniasis in eastern Africa: a randomised trial. PLoS Negl Trop Dis. 2014;8(1):e2613.","journal-title":"PLoS Negl Trop Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1746-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T20:44:56Z","timestamp":1498337096000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1746-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,10]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1746"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1746-1","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,10]]},"article-number":"548"}}